This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Oct 3;386(10001):1319-1320.

doi: 10.1016/S0140-6736(15)61163-1. Epub 2015 Jul 23.

Bisphosphonates, bone, and breast cancer recurrence

Adam Brufsky¹, Aju Mathew²

Affiliations

Affiliations

¹ University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA 15213, USA. Electronic address: brufskyam@upmc.edu.
² University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA 15213, USA.

PMID: 26211825
DOI: 10.1016/S0140-6736(15)61163-1

Free article

Comment

Bisphosphonates, bone, and breast cancer recurrence

Adam Brufsky et al. Lancet. 2015.

Free article

. 2015 Oct 3;386(10001):1319-1320.

doi: 10.1016/S0140-6736(15)61163-1. Epub 2015 Jul 23.

Authors

Adam Brufsky¹, Aju Mathew²

Affiliations

¹ University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA 15213, USA. Electronic address: brufskyam@upmc.edu.
² University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA 15213, USA.

PMID: 26211825
DOI: 10.1016/S0140-6736(15)61163-1

No abstract available

PubMed Disclaimer

Comment on

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet. 2015 Oct 3;386(10001):1353-1361. doi: 10.1016/S0140-6736(15)60908-4. Epub 2015 Jul 23. Lancet. 2015. PMID: 26211824

Similar articles

Bisphosphonates in breast cancer: a triple winner?
Mathew A, Brufsky A. Mathew A, et al. Oncology (Williston Park). 2015 Jan;29(1):37-9. Oncology (Williston Park). 2015. PMID: 25595284 No abstract available.
Adjuvant bisphosphonates for early-stage breast cancer.
Brufsky A. Brufsky A. Lancet Oncol. 2011 Jul;12(7):610-1. doi: 10.1016/S1470-2045(11)70151-6. Lancet Oncol. 2011. PMID: 21708345 No abstract available.
[Bisphosphonates].
Sabourin G. Sabourin G. Perspect Infirm. 2016 Jan-Feb;13(1):71. Perspect Infirm. 2016. PMID: 26998546 French. No abstract available.
Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion.
Eiermann W. Eiermann W. Crit Rev Oncol Hematol. 2010 Apr;74 Suppl 1:S16-7. doi: 10.1016/S1040-8428(10)70006-8. Crit Rev Oncol Hematol. 2010. PMID: 20427028 Review. No abstract available.
Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?
Amoroso V, Petrelli F, Pedersini R, Simoncini EL, Clézardin P, Barni S, Berruti A. Amoroso V, et al. Future Oncol. 2015;11(21):2853-6. doi: 10.2217/fon.15.210. Epub 2015 Sep 25. Future Oncol. 2015. PMID: 26403833 Review. No abstract available.

See all similar articles

Cited by

Emerging strategies for treating metastasis.
Esposito M, Ganesan S, Kang Y. Esposito M, et al. Nat Cancer. 2021 Mar;2(3):258-270. doi: 10.1038/s43018-021-00181-0. Epub 2021 Mar 24. Nat Cancer. 2021. PMID: 33899000 Free PMC article.
Alendronic Acid as Ionic Liquid: New Perspective on Osteosarcoma.
Teixeira S, Santos MM, Fernandes MH, Costa-Rodrigues J, Branco LC. Teixeira S, et al. Pharmaceutics. 2020 Mar 24;12(3):293. doi: 10.3390/pharmaceutics12030293. Pharmaceutics. 2020. PMID: 32213930 Free PMC article.
Bone Metastasis Prognostic Factors in Breast Cancer.
Yazdani A, Dorri S, Atashi A, Shirafkan H, Zabolinezhad H. Yazdani A, et al. Breast Cancer (Auckl). 2019 Feb 22;13:1178223419830978. doi: 10.1177/1178223419830978. eCollection 2019. Breast Cancer (Auckl). 2019. PMID: 30828246 Free PMC article.
Bone metastasis pattern in initial metastatic breast cancer: a population-based study.
Xiong Z, Deng G, Huang X, Li X, Xie X, Wang J, Shuang Z, Wang X. Xiong Z, et al. Cancer Manag Res. 2018 Feb 9;10:287-295. doi: 10.2147/CMAR.S155524. eCollection 2018. Cancer Manag Res. 2018. PMID: 29467583 Free PMC article.
TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42.
Xu S, Zhang Y, Wang J, Li K, Tan K, Liang K, Shen J, Cai D, Jin D, Li M, Xiao G, Xu J, Jiang Y, Bai X. Xu S, et al. Cell Death Differ. 2018 Sep;25(9):1549-1566. doi: 10.1038/s41418-017-0049-4. Epub 2018 Jan 22. Cell Death Differ. 2018. PMID: 29358671 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information